Skip to content

Certipharm

Active Private limited companyfounded 2020active for 6 yearsMolenbaan 50, 2290 VorselaarKBO/BCE: BE 0754.702.164

Lifetime

5 annual accounts with figures on one time axis
peak of €150,680 in 2021
€124,569▲ 45.5%
peak of €113,552 in 2021
€91,689▲ 55.1%
peak of €295,929 in 2023
€102,793▲ 68.2%
€54,580▲ 13×
Board1 name since 2020
1 director
Documentsfilings and deeds
14-08-202614 days late
2025micro format
Gross margin from €85,612 to €124,569Result from €59,104 to €91,689Dividend €50,000Equity from €61,104 to €102,793Debts from €4,166 to €54,580Cash from €46,976 to €136,612

Key points

from the 2025 annual accounts

Equity

€102,793 from €295,929 in 2023

Equity fell by 65% in 2 years.

Turnover

≈ €190,000 estimated

The micro format states no turnover.

Investments

€869 1.6 times depreciation
202120222025

Green is investment, beige is depreciation.

Liquidity

2.85 was 15.32 in 2024

Short-term debts rose from €4,166 to €54,580.

Filings

5 annual accounts 2 late
AprilJune31 JulyOctober20222024

The 2024 accounts came in latest, 18 days after the end of the period.

Position in the sector

€91,689

Higher net result than 89% of companies in office administrative support. The sector median is €15,202, over 10,299 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as Certipharm has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for Certipharm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 2,000 sharesdeed of 24-09-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0754702164
Incorporation Founding capital of €2,000, 2,000 shares · Founded by · appointed as director · published on 24-09-2020 · Gazette deed
First establishment Molenbaan 50, Vorselaar
All 11 events

Comparable companies

same main activity, similar in size and age
Company
Certipharm Vorselaar €157,372 €124,569 65.3% -
Future Marketing Agency Antwerp €163,326 €141,841 65.8% -
VAT Advisory Services Boom €140,609 €148,553 0.7% -
U-NOMIA AUTOMOTIVE SOLUTIONS Stabroek €163,481 €100,941 92.7% -
SFIN Advisory Uccle €159,005 €119,869 55.6% -
DERMO MEDICAL CENTER Ixelles €159,586 €130,944 15.0% 3.5
SQUARE ONE Zaventem €163,083 €136,138 4.8% -

These companies have the same main activity as Certipharm: other business support services (NACE 82990). They are comparable in size and age: total assets between €141,000 and €163,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 22-09-2020Normal situation
Activity
Other business support servicesNACE 82990
Establishment unit
2.307.848.7442290 Vorselaar, since 22-09-2020
Financial year end
31 December
Peppol
Reachable since 02-10-2025
Company details

Annual accounts 2025

€157,372▲ 141%
Filing
Filed on 14-08-2026
Financials

Insights on Certipharm

Certipharm files the micro format. That format states no turnover. The gross margin fell from €150,680 in 2021 to €124,569 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Certipharm

What is the company number of Certipharm?
The company number of Certipharm is 0754.702.164. The VAT number is the same number with BE in front: BE 0754.702.164.
Where is Certipharm based?
The registered office is at Molenbaan 50, 2290 Vorselaar.Company details
What does Certipharm do?
According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of Certipharm?
Certipharm is a private limited company (BV).
When was Certipharm founded?
Certipharm was founded on 22-09-2020.
Is Certipharm still active?
Yes, Certipharm is an active enterprise in the KBO register.
What is the turnover of Certipharm?
The turnover in financial year 2025 is about €190,000. This figure is estimated from the gross margin of €124,569 and 31 comparable companies (NACE 82990). It probably lies between €150,000 and €260,000.Financials
Is Certipharm profitable?
In financial year 2025, Certipharm made a profit of €91,689.
Where can I find the annual accounts of Certipharm?
Certipharm filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Certipharm due?
Certipharm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.